HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thor Willy Ruud Hansen Selected Research

Neonatal Jaundice

10/2020Sixty years of phototherapy for neonatal jaundice: from serendipitous observation to standardized treatment and rescue for millions.
1/2020Sixty years of phototherapy for neonatal jaundice - from serendipitous observation to standardized treatment and rescue for millions.
4/2018Uniform national guidelines do not prevent wide variations in the clinical application of phototherapy for neonatal jaundice.
4/2018Phototherapy is commonly used for neonatal jaundice but greater control is needed to avoid toxicity in the most vulnerable infants.
7/2015Early formation of bilirubin isomers during phototherapy for neonatal jaundice: effects of single vs. double fluorescent lamps vs. photodiodes.
6/2011The role of phototherapy in the crash-cart approach to extreme neonatal jaundice.
8/2010Twists and turns in phototherapy for neonatal jaundice.
6/2010Early isomerization of bilirubin in phototherapy of neonatal jaundice.
12/2005Nils Rosén von Rosenstein and neonatal jaundice in the 18th century.
4/2002Kernicterus: an international perspective.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thor Willy Ruud Hansen Research Topics

Disease

11Neonatal Jaundice
10/2020 - 01/2002
6Jaundice (Icterus)
06/2011 - 01/2002
4Birth Weight (Birth Weights)
01/2020 - 07/2015
2Hyperbilirubinemia
01/2017 - 06/2016
2Kernicterus
06/2010 - 03/2005
1Neonatal Hyperbilirubinemia
06/2016
1Trisomy 13 Syndrome
04/2016
1Neoplasms (Cancer)
01/2012
1Drug-Related Side Effects and Adverse Reactions
09/2010
1Critical Illness (Critically Ill)
09/2010
1Sepsis (Septicemia)
11/2007
1Lung Diseases (Lung Disease)
02/2007
1Necrosis
02/2005
1Teratocarcinoma
02/2005
1Patent Ductus Arteriosus
05/2003
1Hyperoxia
12/2002
1Hypoxia (Hypoxemia)
12/2002
1Hemolysis
12/2002
1Acidosis
12/2002
1Asphyxia (Suffocation)
12/2002
1Infections
12/2002
1Hearing Loss (Hearing Impairment)
09/2002
1Lead Poisoning (Poisoning, Lead)
08/2002

Drug/Important Bio-Agent (IBA)

8BilirubinIBA
01/2017 - 01/2002
2Pharmaceutical PreparationsIBA
09/2010 - 12/2002
2AlbuminsIBA
02/2005 - 12/2002
1Cytostatic AgentsIBA
01/2012
1Proteins (Proteins, Gene)FDA Link
02/2007
1Adenosine Triphosphate (ATP)IBA
02/2007
1LaxativesIBA
12/2005
1SugarsIBA
12/2005
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/2005
1Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA
11/2003
1Ibuprofen (Motrin)FDA LinkGeneric
05/2003
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
12/2002

Therapy/Procedure

10Phototherapy (Light Therapy)
10/2020 - 01/2002
3Therapeutics
12/2005 - 04/2002
2Critical Care (Surgical Intensive Care)
09/2010 - 09/2002
1Duration of Therapy
04/2018
1Cesarean Section (Caesarean Section)
04/2016
1Catheters
11/2007
1Punctures
08/2002